In Memoriam: Bruce Furie — A Pioneer in Hemostasis Research
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), reposted from ISTH on LinkedIn:
”I am deeply saddened by this tremendous loss.
Bruce Furie was a true giant in the field, dedicated leader and enormous contributor to International Society on Thrombosis and Haemostasis (ISTH) and the global thrombosis and hemostasis community, and a mentor to so many.
Sincere condolences to his life and career partner Dr. Barbara Furie and their family.
Bruce will be sorely missed.”
Quoting International Society on Thrombosis and Haemostasis‘s post:
”Bruce Furie, M.D., a longtime ISTH member and influential leader within the field of thrombosis and hemostasis, passed away on November 22, 2025.
Furie’s impact on the field of thrombosis and hemostasis was profound and far-reaching.
As a clinician, scientist and mentor, he contributed to many major discoveries, including the role of y-carboxylation in the synthesis of vitamin K-dependent blood coagulation proteins and the identification of P-selectin and its function as an adhesion molecule.
In 2021, the ISTH awarded honorary membership to Bruce and his wife and scientific collaborator Barbara Furie, Ph.D., recognizing decades of service to the Society.
The pair served as Co-Presidents of the ISTH 2009 Congress in Boston.
Bruce also served as ISTH Executive Officer and ISTH Secretary General.
In 2011, he received the ISTH Distinguished Career BACH Award.
Learn more about his legacy here.”
Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis